Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
2006-006752-35Phase 3Completed
- Sponsor
- Schwarz Pharma
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing Rotigotine with Placebo (2 arms). Primary endpoint: Change from baseline in early morning UPDRS Part III. Started Mar 2007; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-006752-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006752-35.